Comparative statistics by cancer registry

Registry: Comparative statistics by cancer site

Table2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site

(Harare, Zimbabwe, 1993-1997 cases* followed-up until 1999, all races together)

Click on cancer site (ICD-10 code) for comparison
Site ICD-10 No. of cases included Complete FUIncomplete FU: loss to FU% with Complete FU at 5 yearsMedian FU (in months)
Alive/deadAt end of FUNo.%% lost to FU: years from diagnosis
No.%<11-33-5>5
C15Oesophagus131131100.000.00.00.00.00.0100.02.3
C16Stomach12912798.421.61.60.00.00.098.44.8
C18Colon5757100.000.00.00.00.00.0100.014.6
C19-20Rectum676597.023.01.51.50.00.097.016.1
C22Liver13213199.210.80.80.00.00.099.21.0
C32Larynx736994.545.55.50.00.00.094.514.1
C33-34Lung116116100.000.00.00.00.00.0100.02.0
C43Melanoma skin10110099.011.01.00.00.00.099.054.2
C46Kaposi sarcoma151151100.000.00.00.00.00.0100.03.4
C50Breast25825096.983.12.70.40.00.096.939.3
C53Cervix26426098.541.51.10.40.00.098.526.2
C56Ovary6363100.000.00.00.00.00.0100.018.7
C61Prostate646195.334.74.70.00.00.095.316.6
C67Urinary bladder13012797.732.31.50.80.00.097.711.8
C69Eye11611498.321.70.90.90.00.098.342.1
C81Hodgkin lymphoma3939100.000.00.00.00.00.0100.030.6
C82-85+C96Non-Hodgkin lymphoma999798.022.02.00.00.00.098.07.8


Other tables available for this registry:
- Table1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Harare, Zimbabwe, 1993-1997 cases* followed-up until 1999, all races together)
- Table2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site (Harare, Zimbabwe, 1993-1997 cases* followed-up until 1999, all races together)
- Table4: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Harare, Zimbabwe, all races, 1993-1997 cases* followed-up until 1999)




Registry chapter:


Consult the chapter in Cancer survival in developping countries (Volume II)